276 related articles for article (PubMed ID: 26685155)
1. Dopamine selectively remediates 'model-based' reward learning: a computational approach.
Sharp ME; Foerde K; Daw ND; Shohamy D
Brain; 2016 Feb; 139(Pt 2):355-64. PubMed ID: 26685155
[TBL] [Abstract][Full Text] [Related]
2. Cognitive states influence dopamine-driven aberrant learning in Parkinson's disease.
Cavanagh JF; Mueller AA; Brown DR; Janowich JR; Story-Remer JH; Wegele A; Richardson SP
Cortex; 2017 May; 90():115-124. PubMed ID: 28384481
[TBL] [Abstract][Full Text] [Related]
3. A Selective Role for Dopamine in Learning to Maximize Reward But Not to Minimize Effort: Evidence from Patients with Parkinson's Disease.
Skvortsova V; Degos B; Welter ML; Vidailhet M; Pessiglione M
J Neurosci; 2017 Jun; 37(25):6087-6097. PubMed ID: 28539420
[TBL] [Abstract][Full Text] [Related]
4. Dopamine is associated with prioritization of reward-associated memories in Parkinson's disease.
Sharp ME; Duncan K; Foerde K; Shohamy D
Brain; 2020 Aug; 143(8):2519-2531. PubMed ID: 32844197
[TBL] [Abstract][Full Text] [Related]
5. Reward sensitivity deficits modulated by dopamine are associated with apathy in Parkinson's disease.
Muhammed K; Manohar S; Ben Yehuda M; Chong TT; Tofaris G; Lennox G; Bogdanovic M; Hu M; Husain M
Brain; 2016 Oct; 139(Pt 10):2706-2721. PubMed ID: 27452600
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
[TBL] [Abstract][Full Text] [Related]
7. Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study.
Argyelan M; Herzallah M; Sako W; DeLucia I; Sarpal D; Vo A; Fitzpatrick T; Moustafa AA; Eidelberg D; Gluck M
Neuroreport; 2018 May; 29(7):532-540. PubMed ID: 29432300
[TBL] [Abstract][Full Text] [Related]
8. Effects of dopamine on reinforcement learning in Parkinson's disease depend on motor phenotype.
van Nuland AJ; Helmich RC; Dirkx MF; Zach H; Toni I; Cools R; den Ouden HEM
Brain; 2020 Dec; 143(11):3422-3434. PubMed ID: 33147621
[TBL] [Abstract][Full Text] [Related]
9. Selective impairment of prediction error signaling in human dorsolateral but not ventral striatum in Parkinson's disease patients: evidence from a model-based fMRI study.
Schonberg T; O'Doherty JP; Joel D; Inzelberg R; Segev Y; Daw ND
Neuroimage; 2010 Jan; 49(1):772-81. PubMed ID: 19682583
[TBL] [Abstract][Full Text] [Related]
10. Dose dependent dopaminergic modulation of reward-based learning in Parkinson's disease.
van Wouwe NC; Ridderinkhof KR; Band GP; van den Wildenberg WP; Wylie SA
Neuropsychologia; 2012 Apr; 50(5):583-91. PubMed ID: 22223079
[TBL] [Abstract][Full Text] [Related]
11. The role of dopamine in cognitive sequence learning: evidence from Parkinson's disease.
Shohamy D; Myers CE; Grossman S; Sage J; Gluck MA
Behav Brain Res; 2005 Jan; 156(2):191-9. PubMed ID: 15582105
[TBL] [Abstract][Full Text] [Related]
12. Decomposing effects of dopaminergic medication in Parkinson's disease on probabilistic action selection--learning or performance?
Smittenaar P; Chase HW; Aarts E; Nusselein B; Bloem BR; Cools R
Eur J Neurosci; 2012 Apr; 35(7):1144-51. PubMed ID: 22487043
[TBL] [Abstract][Full Text] [Related]
13. Two routes to value-based decisions in Parkinson's disease: differentiating incremental reinforcement learning from episodic memory.
Montaser-Kouhsari L; Nicholas J; Gerraty RT; Shohamy D
bioRxiv; 2024 May; ():. PubMed ID: 38746345
[TBL] [Abstract][Full Text] [Related]
14. Exploring reward-relatedĀ attention selectivity deficits in Parkinson's disease.
Pilgrim MJD; Ou ZA; Sharp M
Sci Rep; 2021 Sep; 11(1):18751. PubMed ID: 34548517
[TBL] [Abstract][Full Text] [Related]
15. Dopamine restores cognitive motivation in Parkinson's disease.
McGuigan S; Zhou SH; Brosnan MB; Thyagarajan D; Bellgrove MA; Chong TT
Brain; 2019 Mar; 142(3):719-732. PubMed ID: 30689734
[TBL] [Abstract][Full Text] [Related]
16. Mind matters: placebo enhances reward learning in Parkinson's disease.
Schmidt L; Braun EK; Wager TD; Shohamy D
Nat Neurosci; 2014 Dec; 17(12):1793-7. PubMed ID: 25326691
[TBL] [Abstract][Full Text] [Related]
17. Null effects of levodopa on reward- and error-based motor adaptation, savings, and anterograde interference.
Palidis DJ; McGregor HR; Vo A; MacDonald PA; Gribble PL
J Neurophysiol; 2021 Jul; 126(1):47-67. PubMed ID: 34038228
[TBL] [Abstract][Full Text] [Related]
18. The role of dopamine in positive and negative prediction error utilization during incidental learning - Insights from Positron Emission Tomography, Parkinson's disease and Huntington's disease.
Mathar D; Wilkinson L; Holl AK; Neumann J; Deserno L; Villringer A; Jahanshahi M; Horstmann A
Cortex; 2017 May; 90():149-162. PubMed ID: 27751503
[TBL] [Abstract][Full Text] [Related]
19. Perceptual decisions based on previously learned information are independent of dopaminergic tone.
Perugini A; Basso MA
J Neurophysiol; 2018 Mar; 119(3):849-861. PubMed ID: 29167328
[TBL] [Abstract][Full Text] [Related]
20. Impact of Parkinson's disease and dopaminergic medication on adaptation to explicit and implicit visuomotor perturbations.
Mongeon D; Blanchet P; Messier J
Brain Cogn; 2013 Mar; 81(2):271-82. PubMed ID: 23313834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]